Ashok Srivastava, MD, PhD, MBA
Medical Officer, Safety
Dr. Srivastava is a Clinician-Scientist and a global leader in cancer drug development and an executive leader who has managed global clinical trials with multi-million-dollar budgets and has mediated the merger and acquisition of several pharma companies. He has led more than 150 global phase 1-4 clinical trials involving several cancers and as an oncologist, he has been profiled in both 2007 and 2011 as one of the “Top Oncologists in America”. Across the globe, he has supervised the regulatory registration, launch and commercialization of phase 1-4 trials. He possesses widespread experience in diverse arenas such as intratumoral injectable oncolytic virus therapy, cytokine-immunotherapy, gene therapy, cell therapy, immunotherapy and antibody-drug conjugates.